American Capital Advisory, LLC has filed its latest 13F report, detailing its investment holdings as of September 30, 2026. The report indicates that the firm has a total value of approximately $292.97 million in reported securities. This filing is significant as it provides insights into the firm's investment strategy and positions in the market.

American Capital Advisory, LLC is based in Ketchum, Idaho, and operates as an investment advisory firm. The company has been active in reporting its holdings, with the latest filing dated October 28, 2026. The firm has consistently submitted 13F reports, showcasing its investment activities and portfolio management strategies.

The filing reveals a total of 1,173 holdings, which include a diverse range of companies across various sectors. Notably, the report lists significant investments in well-known firms such as 3M Co, Abbott Laboratories, and AbbVie Inc. These investments reflect the firm's strategy to diversify its portfolio while maintaining substantial positions in leading companies.

According to the filing, the firm exercises sole investment discretion over its holdings, indicating a focused management approach. The reported securities include a mix of common stocks, with a notable emphasis on healthcare and technology sectors. This aligns with current market trends where these sectors have shown resilience and growth potential.

The impact of this filing may extend to other investment firms and advisors, as it highlights trends in investment strategies and sector allocations. As American Capital Advisory continues to navigate the market, its decisions may influence competitors and other firms in the advisory sector.

Looking ahead, the firm is expected to continue its reporting activities, providing further insights into its investment strategies and market positions. The next filing is anticipated in early 2027, which will shed more light on how the firm adjusts its portfolio in response to market dynamics.